Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Parameswaran Ramachandran

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Nature Immunology|May 21, 2025
Cholinergic regulation of thymocyte negative selectionShaofeng Liu, Chunxing Zheng, Robert Nechanitzky, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 9, 2019
AhR controls redox homeostasis and shapes the tumor microenvironment in BRCA1-associated breast cancerShawn P Kubli, Christian Bassi, Cecilia Roux, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2025
Mutant <i>IDH1</i> cooperates with <i>NPM1c</i> or <i>FLT3</i><sup>ITD</sup> to drive distinct myeloid diseases and molecular outcomesTakashi Sakamoto, Julie Leca, Xin Zhang, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Nature Immunology|May 21, 2025
Cholinergic regulation of thymocyte negative selectionShaofeng Liu, Chunxing Zheng, Robert Nechanitzky, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 9, 2019
AhR controls redox homeostasis and shapes the tumor microenvironment in BRCA1-associated breast cancerShawn P Kubli, Christian Bassi, Cecilia Roux, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2025
Mutant <i>IDH1</i> cooperates with <i>NPM1c</i> or <i>FLT3</i><sup>ITD</sup> to drive distinct myeloid diseases and molecular outcomesTakashi Sakamoto, Julie Leca, Xin Zhang, et al.
Pageof 3